Investigation of Parotid Gland Tumors
MRI with and without IV contrast is the preferred imaging modality for evaluating parotid gland tumors, providing comprehensive information about tumor extent, local invasion, perineural spread, and possible extension into surrounding structures. 1
Initial Diagnostic Approach
- Ultrasound (US) is useful for initial assessment to distinguish parotid versus extraparotid masses and identify features suspicious for malignancy, though it has limitations in visualizing deep lobe lesions 2
- MRI with and without IV contrast provides the most comprehensive evaluation, showing:
- CT with IV contrast can be used when MRI is contraindicated, particularly useful for evaluating bony details and sialoliths 2
- Fine needle aspiration biopsy (FNAB) is essential for distinguishing between benign and malignant lesions, as imaging alone cannot definitively determine malignancy 1, 3
Imaging Features to Assess
- On MRI, features suggesting malignancy include:
- On ultrasound, features suggesting malignancy include:
- On CT, malignant tumors often show:
- Larger mean diameter compared to benign tumors
- Lobulated or irregular shapes
- Ill-defined margins
- Heterogeneous appearance with necrosis, cystic areas, hemorrhage, or calcification 5
Clinical Correlation
- Clinical features that should raise suspicion for malignancy include:
- The presence of these symptoms and signs correlates with higher-grade malignancies and poorer prognosis 6
Advanced Imaging Considerations
- For suspected duct obstruction, consider:
- CT sialography (in absence of acute infection)
- MRI sialography (complementary to anatomic MRI) 2
- FDG-PET/CT is not recommended as an initial imaging study but has established value for staging and surveillance of confirmed parotid malignancy 2
- Advanced MRI techniques like perfusion imaging and texture analysis show promise in differentiating benign from malignant lesions but are not yet used in routine clinical practice 2, 4
Common Pitfalls to Avoid
- Relying solely on imaging to determine benign versus malignant nature; histologic confirmation is required 2, 1
- Underestimating deep lobe involvement when using ultrasound alone 1
- Making decisions about facial nerve sacrifice based on indeterminate diagnoses 1
- Failing to consider intraparotid nodal metastases in high-grade or advanced parotid cancers 1